4//SEC Filing
LANGE LOUIS G 4
Accession 0000950170-25-003552
CIK 0001936258other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 5:57 PM ET
Size
8.3 KB
Accession
0000950170-25-003552
Insider Transaction Report
Form 4
LANGE LOUIS G
Director
Transactions
- Award
Ordinary Shares
2025-01-07+6,960→ 6,960 total - Award
Option (right to buy)
2025-01-06+32,500→ 32,500 totalExercise: $25.85Exp: 2035-01-06→ Ordinary Shares (32,500 underlying)
Holdings
- 24,878(indirect: See footnote)
Ordinary Shares
Footnotes (4)
- [F1]Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date.
- [F2]Each RSU was granted on January 7, 2025 for no consideration.
- [F3]Represents ordinary shares acquired from the Company in an underwritten public offering. The ordinary shares acquired from the Company were placed into and are being held in a trust account for the benefit of the Reporting Person.
- [F4]1/3 of the shares underlying the option will vest on January 6, 2026, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for two years, subject to the Reporting Person's continued service through each such date.
Documents
Issuer
NewAmsterdam Pharma Co N.V.
CIK 0001936258
Entity typeother
Related Parties
1- filerCIK 0001238401
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 5:57 PM ET
- Size
- 8.3 KB